Does Lifetime Exposure to Hormones Predict Pretreatment Cognitive Function in Women Before Adjuvant Therapy for Breast Cancer?

Menopause - United States
doi 10.1097/gme.0b013e3182843eff
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Ovid Technologies (Wolters Kluwer Health)

Related search

Trajectories of Self-Reported Cognitive Function in Postmenopausal Women During Adjuvant Systemic Therapy for Breast Cancer

Psycho-Oncology
PsychiatryMental HealthOncologyExperimentalCognitive Psychology
2015English

Bisphosphonates as Adjuvant Therapy for Breast Cancer

Women's Health
Medicine
2006English

Cost-Effectiveness of Using Prognostic Information to Select Women With Breast Cancer for Adjuvant Systemic Therapy

Health Technology Assessment
MedicineHealth Policy
2006English

Adjuvant Therapy After Preoperative Treatment for Breast Cancer

Breast Cancer Research
Cancer ResearchOncology
2009English

Long Term Adjuvant Therapy for Primary Breast Cancer

BMJ
1996English

Breast-Cancer Adjuvant Therapy With Zoledronic Acid

New England Journal of Medicine
Medicine
2012English

Adjuvant Endocrine Therapy in Early Postmenopausal Breast Cancer

Breast Care
SurgeryOncology
2008English

Mutated Pathways as a Guide to Adjuvant Therapy Treatments for Breast Cancer

Molecular Cancer Therapeutics
Cancer ResearchOncology
2015English

Oral Bisphosphonates as Adjuvant Therapy for Operable Breast Cancer

Clinical Cancer Research
Cancer ResearchOncology
2006English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy